An observational study in Difficult Intubation and Obesity, sponsored by Zagazig University. Not yet recruiting at 1 site in Egypt. Open to participants aged 21 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by Zagazig University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 138 studies in Obesity with a site in Egypt — 32 open to participants now, 39 under way, none of them phase 3. Obesity · Egypt.
Among the 138 studies in Obesity with a site in Egypt, this one is the 15th largest by planned enrollment of the 36 observational ones that give a count, is one of 13 that started in 2026, is one of 36 observational ones, reaches primary completion later than 34 of the 38 other live ones, and was the 136th registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →32 of the 138 studies in Obesity with a site in Egypt are open now. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 18+
Cairo University · Sites in Egypt
Ages 60–70 · Women only
Badr University · Sites in Egypt
Ages 36–58
Cairo University · Sites in Egypt
Ages 40–55
Cairo University · Sites in Egypt
Ages 18–60
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 21 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
138 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 6 · Phase 3 2 · Phase 4 3
First in 2006; this study’s year is marked. 13 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 114 is close to the median of 115 across 2,159 observational studies indexed under Obesity.
Median enrollment 60 across the 102 interventional studies, 100 across the 36 observational. Of the 87 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 138 have an industry lead sponsor. The 10 most frequent:
Zagazig University is the lead sponsor of 462 studies on the registry; 78 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Zagazig University has 8 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
7 of the studies in Obesity with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07397572Cairo UniversityIron Supplementation and Anemia After Sleeve Gastrectomy | 2026-11 |
| NCT06901440Assiut UniversityBariatric Surgery for Obesity | 2026-12 |
| NCT07336797Abdelrahman MahmoudEffect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy | 2026-12-30 |
| NCT07683286Cairo UniversityPilates Exercises Versus Intermittent Fasting Diet on Physical and Metabolic Aging Process in Obese Perimenopausal Women | 2027-01-01 |
| NCT07857395Zagazig UniversityModified El-Ganzouri Risk Index for Predicting Difficult Intubation in Obese Patients | 2027-03-31 |
Add all 7 to your calendar (.ics) → With an account.
Among the 138 studies in Obesity with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This observational study aims to compare the predictive performance of the Modified El-Ganzouri Risk Index (MEGRI) incorporating anthropometric ratios with the original El-Ganzouri Risk Index (EGRI) for predicting difficult intubation in obese adult patients undergoing elective general anesthesia.
Age: 21-65 years old.ASA: II,III.Obese patients (Body Mass Index (BMI) 30-40 kg/m² ) scheduled for elective surgical procedures under general anesthesia
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adult obese patients undergoing elective general anesthesia who will be assessed preoperatively using both the original El-Ganzouri Risk Index and the Modified El-Ganzouri Risk Index, followed by assessment of laryngoscopy and intubation outcomes.
Other: No intervention
This is an observational study. No study intervention is assigned. Patients receive standard anesthetic care, and preoperative airway assessment and intraoperative intubation outcomes are recorded for comparison of the original and Modified El-Ganzouri Risk Index.
Area Under the Receiver Operating Characteristic Curve (AUC) of the Modified El-Ganzouri Risk Index for Predicting Difficult Intubation
The predictive performance of the Modified El-Ganzouri Risk Index (MEGRI) for difficult intubation will be evaluated using receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC).
Time frame: From preoperative airway assessment to completion of endotracheal intubation during surgery.
Area Under the Receiver Operating Characteristic Curve (AUC) of the Original El-Ganzouri Risk Index for Predicting Difficult Intubation
The predictive performance of the original El-Ganzouri Risk Index (EGRI) for difficult intubation will be evaluated using receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC).
Time frame: From preoperative airway assessment to completion of endotracheal intubation during surgery.
Intubation Difficulty Score (IDS)
The Intubation Difficulty Scale score will be recorded during tracheal intubation. An IDS score greater than 5 will indicate difficult intubation.
Time frame: During endotracheal intubation
Sensitivity and Specificity of the Modified and Original El-Ganzouri Risk Indices for Predicting Difficult Intubation
Difficult laryngoscopy will be defined as a Cormack-Lehane grade III or IV laryngeal view.
Time frame: From preoperative airway assessment to completion of endotracheal intubation during surgery
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Mar 2027, 5 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.